June 25, 2020. Supporting the Resilience of Black Men: Culturally Affirming and Responsive Approaches to Engagement, Treatment, and Recovery

Having trouble viewing this email? View it in your browser.

Recovery LIVE! Supporting the Resilience of Black Men: Culturally Affirming and Responsive Approaches to Engagement, Treatment, and Recovery Thursday | June 25, 2020 | 2:00–3:00 p.m. EDT The experiences of Black men with mental illness, substance use disorder, and recovery are unique in ways that have crucial implications for service delivery. SAMHSA’s Bringing Recovery Supports to Scale Technical Assistance Center Strategy (BRSS TACS) invites you to join national experts in a conversation about the experiences of Black men with mental illness, substance use disorder (SUD), or both. Our presenters will highlight current research and describe best practices and promising strategies for supporting the recovery of Black men. Join us for this free, interactive virtual event moderated by Devin Reaves, Executive Director of the Pennsylvania Harm Reduction Coalition. Register For The Virtual Event Registration will close 60 minutes before the event start time. Presenters: Daryl McGraw, Recovery Specialist, C4 Innovations Mosi Kamau Kitwana, Director, Community Healing Network Dr. Daphne C. Watkins, Professor, University of Michigan School of Social Work, and Director, YBMen Project

Systems Failure: LE. Re-Design the System Council of State Governments (CSG) Justice Center. June 2020.

A Message on the Killing of George Floyd

Photo credit: munshots/Unsplash.com As the director of The Council of State Governments (CSG) Justice Center, I share our country’s horror at the killing of George Floyd. A killing made particularly disturbing by the fact that it came at the hands of someone who was vested with the power and responsibility to enforce laws and protect and serve the community. The CSG Justice Center’s tagline is “advancing safety and second chances.” Safety means not just the absence of crime, but also the positive presence of government institutions that people can trust have their best interests at heart. Everyone is entitled to safety and deserves to be served by a government that not only minimizes harm but maximizes well-being. And until we can truly say that every Black person in America can trust in the criminal justice system to treat them fairly and with dignity and respect, our goals to advance safety and second chances for all cannot be achieved. To that end, the CSG Justice Center is committed to using our energy and influence to oppose racism and racial bias and support our nation’s justice systems to live up to their highest ideals. We also recognize that this is a time to reflect on our own work and priorities. As are so many others, we are asking ourselves if we have done enough to advance racial equity through our work. The answer is assuredly no—we can, must, and will do more.   See what we're planning >

FROM OUR PARTNERS

A Series on Racism as a Determinant of Health and Equity

Image credit: Jess Rodrigues/Shutterstock.com The American Public Health Association is hosting a four-part webinar series that will examine the systems, policies, and practices designed to limit and shape opportunities for people of color, and actions that can advance racial equity and justice. The first in the series will take place on Tuesday, June 9, from 2–3:30 p.m. ET.   Register now >

June 2020. Red Flags in Drug Research COVID-19..

GHN News

Twitter

Red Flags Raised on Research 2 top medical journals are reviewing major studies they published on potential COVID-19 treatments (including hydroxychloroquine) after questions about their data surfaced yesterday, Science reports. The papers in The Lancet and the New England Journal of Medicine shared a common source: A little-known company called Surgisphere. A Lancet "expression of concern" acknowledges that “important scientific questions have been raised about data” in a May 22 study that cast doubt on the benefits of hydroxycholoroquine for COVID-19 patients—and suggested it could even be deadly. The news put the brakes on large randomized trials drug trials. The Lancet announced that an independent audit of the data is underway. Nicholas White, a malaria researcher at Mahidol University in Bangkok, is one of the researchers who noticed red flags including details about patient demographics that didn’t add up. “It began to stretch and stretch and stretch credulity,” he says. Another paper, published in the New England Journal of Medicine on May 1, indicated that certain blood pressure drugs did not appear to increase the death risk for COVID-19 patients—also relied on Surgisphere data. The NEJM also issued an EOC indicating that they are seeking evidence of the data’s reliability from the study authors. Surgisphere has not publicly released the data underlying the studies, but is in discussions to provide the study authors with additional details.